Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arexvy
Pharma
GSK raises long-term sales goal—again—despite vaccines woes
After re-adding Blenrep to its portfolio, GSK now expects sales to reach more than £40 billion in 2031. The company's previous target was £38 billion.
Angus Liu
Feb 5, 2025 11:06am
FDA requires Pfizer, GSK to add new warning label on RSV shots
Jan 8, 2025 11:57am
GSK cuts Shingrix deliveries in revised Zhifei China pact
Dec 5, 2024 10:52am
GSK's RSV vaccine sales plummet in wake of guidance changes
Oct 30, 2024 10:41am
GSK's Arexvy shows promise in younger adults
Oct 24, 2024 10:32am
FDA approves Pfizer's RSV shot Abrysvo for all at-risk adults
Oct 23, 2024 11:11am